Foresite Capital Management III, LLC

data from 30/09/2022

Capitalization

$ 37.881 M 37.41 %

Average holding period

12 ans

Performance

$ 98.792 M 118.30 %

Capitalization

Portfolio size

Portfolio performance

Portfolio performance %

Performance compared to S&P 500 (%)

Stock in Foresite Capital Management III, LLC

Date Ticket Name Weight Capitalization Share number First added Performance ($) Performance (%)
2022/09/30 ASND Ascendis Pharma A/S 36.44% 13.805 M $ 133691 2021/12/31 1.377 M $ 11.08 %
2022/09/30 VRNA Verona Pharma PLC. 29.98% 11.356 M $ 1111112 2020/09/30 6.700 M $ 143.90 %
2022/09/30 NTRA Natera, Inc. 18.41% 6.974 M $ 159160 2018/12/31 1.334 M $ 23.64 %
2022/09/30 CBAY Cymabay Therapeutics, Inc. 15.17% 5.746 M $ 1641804 2017/09/30 902.992 K $ 18.65 %